We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Review · July 16, 2021

Potential Modulatory Microbiome Therapies for Preventing/Treating IBD

Pharmaceuticals (Basel, Switzerland)


Additional Info

Disclosure statements are available on the authors' profiles:

Pharmaceuticals (Basel, Switzerland)
Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases
Pharmaceuticals (Basel) 2021 May 26;[EPub Ahead of Print], DV Bunt, AJ Minnaard, S El Aidy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading